The 'skeletal muscle hypothesis in heart failure' revised

European Heart Journal

Volumn 34, Issue 7, 2013, Pages 486-488

  Piepoli, Massimo F ^a   Coats, Andrew J Stewart ^b  

^a GUGLIELMO DA SALICETO HOSPITAL   (Italy)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GLUTAMINE; OMEGA 3 FATTY ACID; TESTOSTERONE;

ARTERY PERFUSION; BLOOD PRESSURE; CACHEXIA; CHEMORECEPTOR; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; DISEASE COURSE; EXERCISE; FUNCTIONAL STATUS; HEART FAILURE; HEMOSTASIS; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IMMUNE SYSTEM; MUSCLE ATROPHY; MUSCLE SPINDLE; PATHOPHYSIOLOGY; PERFUSION PRESSURE; PRESSORECEPTOR; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; TISSUE PERFUSION; VASCULARIZATION;

FEMALE; HEART FAILURE; HUMANS; MALE; MUSCULAR DYSTROPHIES;

EID: 84874233381     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs463     Document Type: Review

References (11)

1. Mann DL. Mechanisms and models in heart failure: a combinatorial approach. Circulation 1999;100:999-1008.
2. Jankowska E, Ponikowski P, Piepoli M, Banasiak W, Anker S, Poole-Wilson P. Autonomic imbalance and immune activation in chronic heart failure. Cardiovascular Res 2006;70:434-445.
3. Coats AJ, Clark AL, Piepoli M, Volterrani M, Poole-Wilson PA. Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J 1994;72(2 Suppl):S36-S39.
4. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, Anker SD, Coats AJS, Poole-Wilson PA. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 2000;102:3060-3067.
5. Mann DL. Inflammatory mediators and the failing heart: past, present and the foreseeable future. Circ Res 2002;91:988-998.
6. Opie LH, Knuuti J. The adrenergic-fatty acid load in heart failure. J Am Coll Cardiol 2009;54:1637-1646.
7. Doehner W, Rauchhaus M, Ponikowski P, Godsland IF, von Haehling S Anker SD, Coats AJS, Poole-Wilson PA . Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 2005;46:1019-1026.
8. Piepoli MF, Guazzi M, Boriani G, Cicoira M, Corrà U, Dalla Libera L, Emdin M, Mele D, Passino C, Vescovo G, Vigorito C, Villani GQ, Agostoni P; Working Group 'Exercise Physiology, Sport Cardiology and Cardiac Rehabilitation', Italian Society of Cardiology. Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I. Eur J Cardiovasc Prev Rehabil 2010;17:637-642.
9. Rehn TA, Munkvik M, Lunde PK, Sjaastad I, Sejersted OM. Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning? Heart Fail Rev 2012;17:421-436.
10. Adamopoulos S, Coats AJ, Brunotte F, Arnolda L, Meyer T, Sleight P. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol 1993;21:1101-1106.
11. Fülster S, Tacke M, Sandek A, Ebner N, Tschöpe C, Doehner W, Anker SD, von Haehling S. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J 2013;34:512-519.